BioEclosion — Grant · €250K

BioEclosion obtained a €250,000 CDTI Neotec grant to bring CeliFast, its rapid point-of-care test for coeliac disease, to market. The month comes from the founder's news listing.

LeadCDTI RoundGrant AnnouncedDec 2017Not counted in totals CityBarcelona SectorHealthtech / DiagnosticsSource I

Something wrong? Suggest a correction →